Cite
[Subclinical hepatitis developing into chronic hepatitis during treatment with phenylindandione and tolbutamide].
MLA
Jacobsen, C. D. “[Subclinical Hepatitis Developing into Chronic Hepatitis during Treatment with Phenylindandione and Tolbutamide].” Nordisk Medicin, vol. 65, Mar. 1961, pp. 331–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=13718587&authtype=sso&custid=ns315887.
APA
Jacobsen, C. D. (1961). [Subclinical hepatitis developing into chronic hepatitis during treatment with phenylindandione and tolbutamide]. Nordisk Medicin, 65, 331–333.
Chicago
Jacobsen, C D. 1961. “[Subclinical Hepatitis Developing into Chronic Hepatitis during Treatment with Phenylindandione and Tolbutamide].” Nordisk Medicin 65 (March): 331–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=13718587&authtype=sso&custid=ns315887.